{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-213373","form_type":"8-K","ticker":"ATOS","cik":"0001488039","company_name":"ATOSSA THERAPEUTICS, INC.","filed_at":"2026-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.353478+00:00","generated_at":"2026-05-14T21:03:26.354868+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Atossa shareholders approve reverse stock split up to 20:1, re-elect directors","bullets":["Reverse stock split amendment approved: 2,336,815 for, 1,866,873 against, 33,271 abstentions.","Three Class II directors re-elected: Galli, Steinhart, Cigler; broker non-votes ~2.2M each.","Ratification of Ernst & Young as auditor for FY 2026 passed: 3.7M for, 370K against, 151K abstentions.","Advisory vote on executive compensation approved: 1.53M for, 444K against, 2.22M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-213373","json":"https://secwatch.observer/filing/0001193125-26-213373.json","markdown":"https://secwatch.observer/filing/0001193125-26-213373.md","text":"https://secwatch.observer/filing/0001193125-26-213373.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526213373/0001193125-26-213373-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488039/000119312526213373/atos-20260507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:03:26.354868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}